References
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
Trevisani F, Frigerio M, Santi V, et al. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis. 2010;42:341–347.
Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–687.
Ray RB, Meyer K, Ray R. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology. 2000;271:197–204.
El-Refaie A, Savage K, Bhattacharya S, et al. HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol. 1996;24:277–285.
Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004;127:S87–S96.
Donato F, Tagger A, Chiesa R, et al. Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma: a case-control study in Italy—Brescia HCC study. Hepatology. 1997;26:579–584.
Gaddikeri S, McNeeley MF, Wang CL, et al. Hepatocellular carcinoma in the noncirrhotic liver. Am J Roentgenol. 2014;203:W34–W47.
Khanna R, Verma SK. Pediatric hepatocellular carcinoma. World J Gastroenterol. 2018;24:3980–3999.
Franco LM, Krishnamurthy V, Bali D, et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis. 2005;28:153–162.
Bianchi L. Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr. 1993;152:63–70.
Limmer J, Fleig WE, Leupold D, et al. Hepatocellular carcinoma in type I glycogen storage disease. Hepatology. 1988;8:531–537.
Kishnani PS, Chuang TP, Bali D, et al. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. Hum Mol Genet. 2009;18:4781–4790.
Kakar S, Burgart LJ, Batts KP, et al. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol. 2005;18:1417–1423.
Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–748.
Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular adenoma: classification, variants and clinical relevance. Semin Diagn Pathol. 2017;34:112–125.
Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–524.
Wang DQ, Carreras CT, Fiske LM, et al. Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib. Genet Med. 2012;14:795–799.
Gleeson D, Newbould MJ, Taylor P, et al. Androgen associated hepatocellular carcinoma with an aggressive course. Gut. 1991;32:1084–1086.
Johnson FL, Feagler JR, Lerner KG, et al. Association of androgenic anabolic steroid therapy with development of hepatocellular carcinoma. Lancet. 1972;16:1273–1276.
Farrell GC, Joshua DE, Uren RF, et al. Androgen-induced hepatoma. Lancet. 1975;22:430–432.
Solbach P, Potthoff A, Raatschen HJ, et al. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterol. 2015;15:60. https://doi.org/10.1186/s12876-015-0288-0.
Gorayski P, Thompson CH, Subhash HS, et al. Hepatocellular carcinoma associated with recreational anabolic steroid use. Br J Sports Med. 2008;42:74–75.
Socas L, Zumbado M, Perez-Luzardo O, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med. 2005;39:e27.
Hardt A, Stippel D, Odenthal M, et al. Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report. Case Rep Pathol. 2012;2012:195607. https://doi.org/10.1155/2012/195607. Epub 2012 Jul 5.
Forman D, Vincent TJ, Doll R, et al. Oral contraceptives and hepatocellular carcinoma. Br Med J (Clin Res Ed). 1986;292:1355–1357.
Forman D, Vincent TJ, Doll R. Cancer of the liver and the use of oral contraceptives. Br Med J (Clin Res Ed).1986; 292: 1357–61.
Smalley SR, Moertel CG, Hilton JF, et al. Hepatoma in the noncirrhotic liver. Cancer. 1988;62:1414–1424.
Brancatelli G, Federle MP, Grazioli L, et al. Hepatocellular carcinoma in noncirrhotic liver: CT, clinical and pathologic findings in 39 U.S. residents. Radiology. 2002;222:89–94.
Sechi A, Deroma L, Lapolla A, et al. Fertility and pregnancy in women affected by glycogen storage disease type I: results of a multicenter Italian study. J Inherit Metab Dis. 2013;36:83–89.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ling, C., Khalid, S., Martin, D. et al. HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough. Dig Dis Sci 64, 3440–3445 (2019). https://doi.org/10.1007/s10620-019-05920-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-019-05920-z